Researchers at the School of Medicine have found that a drug used to treat multiple sclerosis patients may also help vision loss in those with the relapsing form of the disease, according to a press release.
Natalizumab is a drug that slows the disability and reduces relapse rates of multiple sclerosis patients.
Researchers found that vision loss was reduced by as much as 47 percent among people taking the drug compared to those taking the placebo.
Vision loss is one of the most common and disabling symptoms of MS.
"Not only do the findings of the study add to our understanding of the effects of Natalizumab, but the results provide strong validation for a simple, sensitive, cost-effective and clinically meaningful measure of visual function in MS," said Nicholas LaRocca, associate vice president of Health Care Delivery and Policy Research at the National MS Society.
